Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Residual antimicrobial activity describes the **ability of a disinfectant, coating, or drug** to maintain its antimicrobial effect over a period after initial application[6][7]. The term is most often used in the context of surface treatments in healthcare, food processing, or public spaces, where it is desirable for protection against microbial contamination to persist even after the original agent is no longer actively reapplied. This activity depends both on the chemical stability of the antimicrobial agent and the physical or chemical environment (e.g., binding to surfaces, slow release from matrices, resistance to degradation)[6][7]. The concept is distinct from specific molecular targets, mechanisms, or biological roles of classical therapeutic targets like receptors, enzymes, or ion channels. Residual activity can contribute to infection control and public health, but residual presence of antimicrobials carries safety and resistance risks[5][7].
Maintained microscopic concentrations inhibit/kills microbes over extended periods\nMay disrupt microbial membranes or target cell wall synthesis depending on substance used[7][5][6]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Residual antimicrobial activity.